Exemestane is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Upsher-smith Laboratories, Inc.. The primary component is Exemestane.
Product ID | 0832-0595_1110149a-fd25-4717-a01d-7f8a8ace0c50 |
NDC | 0832-0595 |
Product Type | Human Prescription Drug |
Proprietary Name | Exemestane |
Generic Name | Exemestane |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-07-27 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA209208 |
Labeler Name | Upsher-Smith Laboratories, Inc. |
Substance Name | EXEMESTANE |
Active Ingredient Strength | 25 mg/1 |
Pharm Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2017-07-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA209208 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-07-27 |
Ingredient | Strength |
---|---|
EXEMESTANE | 25 mg/1 |
SPL SET ID: | f8bd17b4-5289-45bb-8095-de89dc8d39ed |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0054-0080 | Exemestane | Exemestane |
0378-5001 | Exemestane | exemestane |
0832-0595 | Exemestane | Exemestane |
44278-025 | Exemestane | EXEMESTANE |
47781-108 | Exemestane | Exemestane |
50090-5193 | Exemestane | Exemestane |
51991-005 | Exemestane | Exemestane |
59651-516 | Exemestane | Exemestane |
59762-2858 | EXEMESTANE | Exemestane |
63629-2056 | Exemestane | Exemestane |
65162-240 | Exemestane | Exemestane |
68382-383 | Exemestane | Exemestane |
69097-316 | EXEMESTANE | exemestane |
70771-1374 | Exemestane | Exemestane |
71921-190 | Exemestane | Exemestane |
0009-7663 | Aromasin | exemestane |